Bureau VeritasBVI
BVI logo
Fair Value
€32.23
Share price01 Aug
€27.6614.2% undervalued intrinsic discount
Loading
1Y4.61%
7D2.52%

Global Regulations And Cybersecurity Will Shape Future TIC Markets

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
02 Mar 25
Updated
01 Aug 26
Views
148
Not Invested

Last Update 01 Aug 26

Fair value Increased 2.43%

BVI: LEAP 28 Portfolio Shift And Margin Focus Will Drive Medium Term Upside

Bureau Veritas sees its analyst price target referenced around €31.44, with the latest revision in this valuation update supported by analysts citing adjusted assumptions for fair value, discount rate, revenue growth, profit margin and future P/E multiples.

Analyst Commentary

Recent research on Bureau Veritas offers a mix of optimism and caution around the stock's execution and valuation. Price targets have been adjusted in both directions in 2026, and some major firms have changed how prominently they feature the stock in their regional lists. This gives you a useful snapshot of how different analysts currently frame the risk and reward balance.

Bullish Takeaways

  • Bullish analysts support the current €31.44 reference price target as a fair reflection of updated assumptions on fair value and future P/E multiples for Bureau Veritas.
  • The upward revision from an earlier €26.95 target suggests that some models now allow for stronger value recognition if the company executes in line with their refreshed expectations.
  • Recent upgrades from certain brokers indicate confidence that Bureau Veritas can meet or manage the assumptions embedded in revised discount rates and margin forecasts.
  • Supportive research views the current valuation as more aligned with the analysts' long term framework following the latest target increase.

Bearish Takeaways

  • Bearish analysts have trimmed their price targets, including a €1 reduction referenced in recent commentary, which signals caution around the upside implied by prior models.
  • JPMorgan provides a reference point for this more cautious stance and shows that not all large brokers share the same conviction around Bureau Veritas at current levels.
  • The removal of Bureau Veritas from the European Conviction List at Goldman Sachs highlights a shift toward a more neutral or selective positioning on the stock.
  • These more cautious views point to concerns that execution, margin delivery, or valuation multiples may not fully support the higher end of target ranges without clearer evidence.

What’s in the News for Bureau Veritas

  • Bureau Veritas reported steady organic revenue growth in the first half of 2026, with a sequential improvement in Q2 and continued margin expansion. Source: company results update titled “Delivering on Our Commitments With Higher Sequential Organic Growth in Q2 and Continuous Margin Improvements”.
  • The company is progressing with its LEAP | 28 plan, which includes portfolio rotation through acquisitions and divestments, and an upgraded full year 2026 guidance that targets mid to high single digit organic revenue growth. Source: Bureau Veritas H1 2026 update.
  • Bureau Veritas plans to exit Oil & Petrochemicals and Coal testing and inspection, and Government Services, while increasing exposure to markets that it describes as higher growth and higher margin. Source: LEAP | 28 strategy communication.
  • A joint venture between AECOM and Bureau Veritas has been selected as Independent Certifier for The Wave, Stage 1, a new dual track rail line from Beerwah to Caloundra that supports the Queensland Government’s 2032 Delivery Plan and is intended to improve regional connectivity on the Sunshine Coast. Source: client announcement.
  • Shareholders approved a cash dividend of €0.92 per share for the financial year ended 31 December 2025, payable on 28 May 2026, with an ex date on 26 May 2026 on positions closed on 27 May 2026. Source: Bureau Veritas combined shareholder meeting on 19 May 2026.

Valuation Changes for Bureau Veritas

  • Fair value has risen slightly from €31.47 to €32.23, an increase of around 2.4%.
  • The discount rate has edged lower from 7.27% to 7.20%.
  • The euro revenue growth assumption has increased from 3.85% to 4.93%.
  • The euro profit margin assumption has moved up from 9.78% to 10.12%.
  • The future P/E has decreased from 23.52x to 22.40x, a reduction of around 4.8%.
0 viewsusers have viewed this narrative update

Key Takeaways

  • Growth in regulatory requirements and global supply chain complexity is strengthening demand for Bureau Veritas's certification and risk mitigation services, ensuring stable recurring revenues.
  • Strategic expansion in sustainability, cybersecurity, and digitalization positions the company to capture higher-margin growth, with M&A bolstering scale and cross-selling opportunities.
  • Heavy dependence on acquisitions, currency exposure, digital transformation challenges, and regulatory shifts create multiple risks to profit growth and revenue stability across key segments.

Catalysts

About Bureau Veritas
    Provides laboratory testing, inspection, and certification services.
What are the underlying business or industry changes driving this perspective?
  • Bureau Veritas is set to benefit from continually increasing global regulatory requirements in safety, health, and decarbonization, particularly in sectors like Marine & Offshore and Building & Infrastructure, which provide a stable and recurring revenue base as regulation-driven demand accelerates across multiple geographies.
  • The company's rapid expansion into high-growth areas such as sustainability and cybersecurity services positions it to capture outsized revenue gains and potential margin uplift as client demand for ESG reporting, supply chain audits, renewable energy projects, and cyber assurance intensifies globally.
  • Ongoing complexity and globalization of supply chains is driving customer demand for risk mitigation, supply chain resilience assessment, and certification solutions, reinforcing Bureau Veritas's role as a trusted third-party (boosting both revenues and recurring cash flow).
  • Digitalization initiatives, including AI-powered inspection tools and modernization of operational systems, are expected to improve operational leverage and drive significant cost efficiencies, likely supporting higher net margins over the medium term.
  • The disciplined, bolt-on M&A strategy focused on scaling in fragmented, high-growth TIC markets, alongside the integration and optimization of recent acquisitions, is set to enhance cross-selling opportunities, expand the company's addressable markets, and support multi-year top line acceleration and margin normalization as synergies are realized.
Bureau Veritas Earnings and Revenue Growth

Bureau Veritas Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Bureau Veritas's revenue will grow by 4.9% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 7.5% today to 10.1% in 3 years time.
  • Analysts expect earnings to reach €789.0 million (and earnings per share of €1.74) by about August 2029, up from €503.6 million today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 22.4x on those 2029 earnings, down from 24.4x today. This future PE is greater than the current PE for the GB Professional Services industry at 9.8x.
  • Analysts expect the number of shares outstanding to grow by 0.12% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.2%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Bureau Veritas' continued M&A strategy, especially involving bolt-on acquisitions in high-growth but nascent markets like sustainability and cybersecurity, is resulting in temporary margin dilution and heightened integration risks; if these acquisitions cannot be quickly scaled or fail to achieve divisional margin levels, longer-term earnings and net margin targets may be pressured.
  • The company's exposure to currency fluctuations, highlighted by recent negative ForEx impacts (e.g., minus 2.3% in H1 and potential -4% for the full year), introduces a persistent volatility risk to reported revenue and margins, particularly as global macroeconomic conditions remain uncertain and the euro exhibits ongoing strength.
  • Structural reorganization and acceleration of digital transformation (including restructuring costs and modernization of digital operating systems) may present execution risks; failure to achieve anticipated efficiencies, or delays in integrating new business models and digital solutions, could limit expected margin improvement and elevate operating costs.
  • The portfolio's reliance on regulatory-driven services for approximately half of revenues presents long-term risk if regulatory harmonization or automation reduces the demand for third-party inspection, testing, and certification-potentially impacting both the addressable market and future revenue growth rates.
  • Emerging signs of moderating growth or underperformance in key segments or geographies (e.g., slow start in Agri-Food due to Brazil weakness, contraction in China's B&I public spending, reliance on early U.S. consumer pre-ordering) point to market-specific vulnerabilities; if these persist or spread, they could drag on consolidated organic growth and earnings expansion.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of €32.23 for Bureau Veritas based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €38.5, and the most bearish reporting a price target of just €26.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €7.8 billion, earnings will come to €789.0 million, and it would be trading on a PE ratio of 22.4x, assuming you use a discount rate of 7.2%.
  • Given the current share price of €27.66, the analyst price target of €32.23 is 14.2% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Bureau Veritas?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

€32.23
vs €27.6614.2% undervalued intrinsic discount
PastFuture08b2015201820212024202620272029Revenue €7.8bEarnings €789.0m
4.9%
Revenue growth
10.1%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Bureau Veritas

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Excellent balance sheet average dividend payer.

Market cap€12.3b
PB7.4x
Estimated Growth5.0%
Dividend Yield3.3%
Full analysis

CEO & management

Hinda Gharbi
CEO
5.4yrs
CEO Tenure

Provides laboratory testing, inspection, and certification services.